Exact Sciences Corporation

EXAS

Exact Sciences Corporation reported robust revenue growth for the fiscal year ended December 31, 2025, generating $3.25 billion in total revenue.

NASDAQ

Healthcare

Medical - Diagnostics & Research

Madison, WI, US6,900 employeesexactsciences.com

$104.91

+0.00(0.0%)

52W $40.31 – $104.91

AI-generated

Exact Sciences Corporation reported robust revenue growth for the fiscal year ended December 31, 2025, generating $3.25 billion in total revenue.

Revenue breakdown: Service (47.1%), Product (35.4%), Product And Service Other (10.9%).

$20.0BMkt Cap

$3.3BRev TTM

-$209MNI TTM

-95.7xP/E TTM

Latest Earnings

10-K

FY FY2025Feb 12, 2026

Exact Sciences Corporation reported robust revenue growth for the fiscal year ended December 31, 2025, generating $3.25 billion in total revenue. Despite this top-line expansion, the company recorded a net loss of $207.9 million, an improvement in operational efficiency reflected in a gross profit of $2.26 billion. The gross margin stood at approximately 69.5%, driven by a cost of sales...

Read full analysis View SEC Filing

What Changed Recently

Asset Acquisition+6 More

Mar 22, 2026

Entry into a Material Definitive Agreement. Exact has outstanding 0.3750% Convertible Senior Notes due 2027 (the “ 2027 Notes ”), 0.3750% Convertible Senior Not

View filing →

Other Event

Mar 19, 2026

Other Events. As previously reported, on November 19, 2025, Exact Sciences Corporation, a Delaware corporation (“ Exact ”), entered into an Agreement and Plan o

View filing →

Shareholder Vote

Feb 19, 2026

Submission of Matters to a Vote of Security Holders. On February 20, 2026, Exact Sciences Corporation, a Delaware corporation (“ Exact ”), held a special meetin

View filing →

View all recent events →

Fundamentals

How The Business Makes Money

Revenue by Segment

Service47.1%($4.0B)

Product35.4%($3.0B)

Product And Service Other10.9%($926M)

International Sales6.7%($566M)

Revenue by Geography

US93.3%($7.9B)

Non Us6.7%($566M)

Analyst View

Peer Companies

Company	Price	Change	Market Cap	P/E
ROIVRoivant Sciences Ltd.	$28.30	+1.65%	$20.3B	-24.1
RVMDRevolution Medicines, Inc...	$99.12	+0.49%	$19.6B	-16.2
VTRSViatris Inc.	$13.45	-1.32%	$15.5B	-4.4
SMMTSummit Therapeutics Inc.	$19.39	+2.46%	$14.4B	-10.8
BBIOBridgeBio Pharma, Inc.	$73.22	-1.65%	$14.2B	-18.8
GHGuardant Health, Inc.	$93.89	+3.01%	$12.3B	-26.3
RVTYRevvity, Inc.	$89.13	+1.38%	$10.0B	40.8
ICLRICON Public Limited Compa...	$114.44	+2.71%	$8.7B	13.0

Company Profile

CIK0001124140

ISINUS30063P1057

CUSIP30063P105

Phone608 284 5700

Address5505 Endeavor Lane, Madison, WI, 53719, US

SEC EDGAR